Yiqing Wang is a reporter with The Cancer Letter. She joined the publication in 2024.
Before joining The Cancer Letter, Yiqing was a freelance reporter with bylines in The Pittsburgh Post-Gazette, Texas Monthly, Michigan Advance and Fairfax Times. She graduated with a M.S. in Journalism at Northwestern University, where she contributed investigative projects about FDA drug shortage and CPAP breathing machine at Propublica.
Yiqing graduated from Bryn Mawr College with a Bachelor of Political Science and French in 2023.
Before joining The Cancer Letter, Yiqing was a freelance reporter with bylines in The Pittsburgh Post-Gazette, Texas Monthly, Michigan Advance and Fairfax Times. She graduated with a M.S. in Journalism at Northwestern University, where she contributed investigative projects about FDA drug shortage and CPAP breathing machine at Propublica.
Yiqing graduated from Bryn Mawr College with a Bachelor of Political Science and French in 2023.
Podcast
Two decades ago, the discovery of the EGFR mutation transformed lung cancer treatment. The finding led to dramatically improved survival rates and ushered in the era of precision medicine and molecular profiling for lung cancer.
Over the last 45 years, prevention and screening interventions have made a greater contribution to averting cancer deaths than have improvements in treatment, according to a modeling study led by researchers at NCI.
Despite steady progress in reducing overall cancer mortality rates, cancer incidence in women is rising, according to the American Cancer Society’s “Cancer Statistics, 2025” report. Incidence rates in women 50-64 years of age have surpassed those in men, and rates in women under 50 are now 82% higher than their male counterparts, up from 51% higher in 2002. In 2021, for the first time, lung cancer incidence was higher in women under 65 than in men.
Capitol Hill
Robert F. Kennedy Jr., President-elect Donald Trump’s choice for HHS secretary, is unfit for that role and should not be confirmed, 77 Nobel laureates said in a letter to members of the U.S. Senate.
NCI is establishing an Early-Onset Cancer Initiative to address the reported rise in early-onset cancer. The initiative will focus on the biological mechanisms of early-onset cancer, the interactions between several known risk factors, and prevention strategies.
